Head-to-head · WeighScore
Andrew Meds vs Breeze Meds
The verdict
Breeze Meds takes it — 72.4/100 to 67.1/100.
Breeze Meds grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Charges nothing until a provider approves you — but keeps its pricing inside the intake.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Andrew Meds | Breeze Meds |
|---|---|---|
| WeighScore | 67.1/100 | 72.4/100 |
| Grade | C | C |
| Scorecard rank | #177 | #56 |
| Semaglutide | $199/mo (product page; two live intake funnels price semaglutide differently) | From $199/mo |
| Tirzepatide | $299/mo (product page; neither GLP-1 funnel offered tirzepatide when walked) | From $299/mo first month, $399/mo thereafter |
| Coverage | All 50 states plus Washington, D.C. | All 50 states |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Injection only |
Graded #177 · C
Strengths
- States its compounding class in plain language on the product pages — a 503(A) pharmacy or a 503(B) outsourcing facility — which most of the field leaves unstated
- Names the prescribing practice in the footer of every page
- Prices sit on the product pages before any intake, and free expedited shipping is stated rather than added at checkout
- Serves all 50 states and the District of Columbia, stated in the footer without a hedge
Where it loses points
- Three live semaglutide figures the site never reconciles: $199 a month on the product page, $99 a month in the microdosing funnel, and $149 for a four-week supply in the second funnel
- Every Get Started button on the compounded semaglutide page lands on a microdosing intake, which is a different program from the one the page describes
- Both GLP-1 intakes ended offering only semaglutide, so whether tirzepatide can be bought through the current funnels is unclear
- The funnel promises a 100% success guarantee and a money-back weight-loss guarantee while the Terms say refunds are not offered for partially used subscription periods
- The pharmacy class is stated but no pharmacy is named, and no individual clinician or NPI appears anywhere
- An oral tirzepatide product is advertised on both GLP-1 pages and every link to it resolves to a page that does not list it
Graded #56 · C
Strengths
- Nothing charged until a provider approves you, and the consult is free if you go ahead
- One inclusive price covering consult, medication, supplies, shipping and support
- LegitScript certified, all 50 states, cancel or change plan at any time
- NAD+ injections offered alongside the GLP-1 line
Where it loses points
- The public site names no molecule behind its "from $199" — tirzepatide pricing appears only inside the intake
- Every quoted figure is for the LOWEST dose; the funnel says higher doses may cost more
- An $80 consultation fee applies if you are approved and then decline
- Injection only, compounded only, with no published lab program
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 536 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.